WILMINGTON, DE — Phreesia, Inc. (NYSE: PHR) has reported robust financial results for the fiscal fourth quarter and full year ended January 31, 2025, underscoring its continued growth and operational improvements. The healthcare services company highlighted double-digit revenue growth, improved profitability, and progress in expanding its client base.
The company posted total revenue of $109.7 million for the fourth quarter, a 15% increase year-over-year, while fiscal 2025 revenue reached $419.8 million, an 18% growth compared to fiscal 2024. Phreesia’s average number of healthcare services clients (AHSCs) grew by 10% in the fourth quarter to 4,341 and by 17% year-over-year to 4,203 for fiscal 2025.
Phreesia’s shift toward profitability was evident in its significant reduction in net losses, narrowing to $6.4 million for the fourth quarter, compared to $30.6 million in the same period last year. Adjusted EBITDA reached $16.4 million for the quarter, a marked improvement from negative $3.5 million during the same quarter last year. For the full fiscal year, net loss declined to $58.5 million from $136.9 million in fiscal 2024, while adjusted EBITDA swung to $36.8 million from negative $35.4 million.
“We are pleased with our solid finish to fiscal 2025,” said Chaim Indig, CEO and Co-Founder of Phreesia. “I am excited about the new products we have introduced over the past several quarters that improve medication adherence and the overall patient and provider experience.”
Phreesia also delivered strong cash flow results, with $16.3 million in net cash provided by operating activities during the fourth quarter, compared to a net cash use of $3.1 million during the same period last year. Free cash flow turned positive to $9.2 million in the quarter, compared to negative $10.9 million a year ago. For fiscal 2025, free cash flow reached $8.3 million, reversing negative $57.5 million in fiscal 2024.
Fiscal 2026 Outlook Remains Positive
Looking ahead, Phreesia reaffirmed its fiscal 2026 guidance, projecting revenue between $472 million and $482 million, alongside adjusted EBITDA ranging from $78 million to $88 million. The company also expects continued growth in AHSCs to approximately 4,500, with increased total revenue per AHSC.
Phreesia noted its strong cash position of $84.2 million as of January 31, 2025, along with its operating cash flow and credit facility with Capital One, would provide the flexibility needed to meet its objectives.
“Our performance this year reflects our focus on operational discipline and efficiency,” Indig added. “We are confident that our strategy and resources will enable us to continue delivering value to our clients and achieving our growth ambitions in the coming year.”
With fiscal 2025 marking a turning point in profitability and operational execution, Phreesia is well-positioned to maintain its momentum and capitalize on opportunities in fiscal 2026.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.